Exocytotic release of creatine in rat brain

Synapse

Volumn 60, Issue 2, 2006, Pages 118-123

  Almeida, Ligia S ^a   Salomons, Gajja S ^a   Hogenboom, Francois ^a   Jakobs, Cornelis ^a   Schoffelmeer, Anton N M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Calcium; Creatine; GABA; Guanidinoacetate; Neuromodulator

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOPYRIDINE; CALCIUM; CARRIER PROTEIN; CAUDATE PUTAMEN; CREATINE; POTASSIUM CHANNEL BLOCKING AGENT; SODIUM CHANNEL BLOCKING AGENT; SODIUM DEPENDENT CREATINE TRANSPORTER SLC6A8; SODIUM ION; TETRODOTOXIN; TRITIUM; UNCLASSIFIED DRUG;

ACTION POTENTIAL; AMINO ACID SYNTHESIS; AMINO ACID TRANSPORT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN METABOLISM; BRAIN SLICE; CONTROLLED STUDY; ENERGY METABOLISM; EXOCYTOSIS; HIPPOCAMPUS; MALE; MENTAL PERFORMANCE; NEOCORTEX; NERVE CELL; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PUTAMEN; RAT;

ACTION POTENTIALS; ANIMALS; BRAIN; CALCIUM; CREATINE; ELECTRIC STIMULATION; ENERGY METABOLISM; EXOCYTOSIS; GABA AGONISTS; MALE; MEMBRANE TRANSPORT PROTEINS; NEURONS; NEUROTRANSMITTER AGENTS; ORGAN CULTURE TECHNIQUES; POTASSIUM CHANNEL BLOCKERS; RATS; RATS, WISTAR; RECEPTORS, GABA-A; SODIUM CHANNEL BLOCKERS; SODIUM CHANNELS; SYNAPTIC TRANSMISSION; TRITIUM;

EID: 33745033499     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20280     Document Type: Article

References (29)

1. Almeida LS, Verhoeven NM, Roos B, Valongo C, Cardoso ML, Vilarinho L, Salomons GS, Jakobs C. 2004. Creatine and guanidino-acetate: diagnostic markers for inborn errors in creatine biosynthesis and transport. Mol Genet Metab 82:214-219.
2. Aronson JK. 1992. Potassium channels in nervous tissue. Biochem Pharmacol 43:11-14.
3. Braissant O, Villard AM, Henry H, Speer O, Wallimann T, Bachmann C. 2005. Synthesis and transport of creatine in the central nervous system. In: Jakobs C, Stöckler-Ipsiroglu S, editors. Clinical and molecular aspects of defects in creatine and polyol metabolism. Heilbronn: SPS Verlagsgesellschaft. p 49-63.
4. De Deyn PP, Macdonald RL. 1990. Guanidino compounds that are increased in cerebrospinal fluid and brain of uremic patients inhibit GABA and glycine responses on mouse neurons in cell culture. Ann Neurol 28:627-633.
5. De Deyn PP, D'Hooge R, Van Bogaert P-P, Marescau B. 2001. Endogenous guanidino compounds as uremic toxins. Kidney Int 59:77-83.
6. Gu Y, Ge SY, Ruan DY. 2004. Effect of 4-aminopyridine on synaptic transmission in rat hippocampal slices. Brain Res 1006:225-232.
7. Item CB, Stöckler S, Stromberger C, Mühl A, Alessandri MG, Bianchi MC, Tosetti M, Fornai F, Cioni G. 2001. Arginine:glycine amidinotransferase (AGAT) deficiency: the third inborn error of creatine metabolism in humans. Am J Hum Genet 69:1127-1133.
8. Klivenyi P, Ferrante RJ, Matthews RT, Bogdanov MB, Klein AM, Andreassen OA, Mueller G, Wermer M, Kaddurah-Daouk R, Beal MF. 1999. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat Med 5:347-350.
9. Koga Y, Takahashi H, Oikawa D, Tachibana T, Denbow DM, Furuse M. 2005. Brain creatine functions to attenuate acute stress responses through gabanergic system in chicks. Neuroscience 132:65-71.
10. 3H]aminobutyric acid in rabbit caudate nucleus slices. J Neurochem 46:1102-1108.
11. Matthews RT, Ferrante RJ, Kliveni P, Yang L, Klein AM, Mueller G, Kaddurah-Daouk R, Beal MF. 1999. Creatine and cyclocreatine attenuate MPTP neurotoxicity. Exp Neurol 157:142-149.
12. Matthews RT, Yang L, Jenkins BG, Ferrante RJ, Rosen BR, Kaddurah-Daouk R, Beal MF. 1998. Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease. J Neurosci 18:156-163.
13. Middlemiss DN, Hutson PH. 1990. Measurement of the in vitro release of endogenous monoamine neurotransmitters as a means of identification of prejunctional receptors. J Neurosci Methods 34:23-28.
14. Nash SR, Giros B, Kingsmore SF, Rochelle JM, Stuter ST, Gregor P, Seldin MF, Caron MG. 1994. Cloning, pharmacological characterization, and genomic localization of the human creatine transporter. Receptors Channels 2:165-174.
15. A receptors by guanidinoacetate: a novel pathophysiological mechanism. Neurobiol Dis 11:298-307.
16. Orrego F. 1979. Criteria for the identification of central neurotransmitters and their application to studies with some nerve tissue preparations in vitro. Neuroscience 4:1037-1057.
17. Salomons GS, van Dooren SJM, Verhoeven NM, Cecil KM, Ball WS, Degrauw TJ, Jakobs C. 2001. X-linked creatine transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome. Am J Hum Genet 68:1497-1500.
18. Schulze A, Hess T, Wevers T, Mayatepek E, Bachert P, Marescau B, Knopp MV, De Deyn PP, Bremer HJ, Rating D. 1997. Creatine deficiency syndrome caused by guanidinoacetate methyltransferase deficiency: diagnostic tools for a new inborn error of metabolism. J Pediatr 131:626-631.
19. Schoffelmeer AN, De Vries TJ, Wardeh G, van de Yen HW, Vanderschuren LJ. 2002. Psychostimulant-induced behavioral sensitization depends on nicotinic receptor activation. J Neurosci 22:3269-3276.
20. 3H-noradrenaline release from rat brain slices through presynaptic opiate receptors and α-adrenoceptors. Eur J Pharmacol 87:449-458.
21. 3H-noradrenaline release from rat neocortex slices: role of calcium ions and transmitter pools. Neurochem Int 3:129-136.
22. A receptor subtypes. Pharmacol Rev 47:181-234.
23. Smith KJ, Felts PA, John GR. 2000. Effects of 4-aminopyridine on demyelinated axons, synapses and muscle tension. Brain 123:171-184.
24. Sora I, Richman J, Santoro G, Wei H, Wang Y, Vanderah T, Horvath R, Nguyen M, Waite S, Roeske WR, Yamamura HI. 1994. The cloning and expression of a human creatine transporter. Biochim Biophys Res Com 204:419-427.
25. Stöckler-Ipsiroglu S, Holzbach U, Hanefeld F, Marquardt I, Helms G, Requardt M, Hänicke W, Frahm J. 1994. Creatine deficiency in brain: a new treatable inborn error of metabolism. Pediatr Res 36:409-413.
26. Tabrizi SJ, Blamire AM, Manners DN, Rajagopolan B, Styles P, Schapira AH, Warner TT. 2003. Creatine therapy for Huntington's disease: clinical and MRS findings in a 1-year pilot study. Neurology 61:141-142.
27. Tachikawa M, Fukaya M, Terasaki T, Ohtsuki S, Watanabe M. 2004. Distinct cellular expressions of creatine synthetic enzyme GAMT and creatine kinases uCK-Mi and CK-B suggest a novel neuron-glial relationship for brain energy homeostasis. Eur J Neurosci 20:144-160.
28. Wang YE, Esbensen P, Bentley D. 1998. Arginine kinase expression and localization in growth cone migration. J Neurosci 18:987-998.
29. Wyss M, Kaddurah-Douk R. 2000. Creatine and creatinine metabolism. Physiol Rev 80:1107-1213.